Neurocrine Biosciences (NBIX) Tops Q3 EPS by 58c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $155.64 -1.71%
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $2.17, $0.58 better than the analyst estimate of $1.59. Revenue for the quarter came in at $794.9 million versus the consensus estimate of $748.62 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
